Life Sciences Call 2003 - Molecular Mechanisms and MethodsLS03-157

Developing the foundation for tests for the early diagnosis of cALD


Developing the foundation for tests for the early diagnosis of cALD
Principal Investigator:
Institution:
Projekttitel:
Developing the foundation for tests for the early diagnosis of cALD
Status:
Abgeschlossen (01.01.2004 – 31.08.2008) 56 Monate
Fördersumme:
€ 400.000

Kurzzusammenfassung:

The goal of the project is to develop the fundamental principles for tests that allow an early identification of the cerebral form of the X-ALD disease and are suitable for monitoring relevant therapies. X-ALD is an inheritable metabolic disorder that damages the central nervous system and leads to the early death of patients.

X-Linked Adrenoleucodystrophy (X-ALD) can either result in cerebral inflammation and demyelination (cALD) causing the early death of patients or in a degenerative disease of the spinal cord (AMN) causing failure of the motor system. Bone marrow transplantations can positively affect the course of the disease, but are risky and can only be considered for a limited number of patients. In order to develop the tests described above, the molecular mechanism that causes the inflammatory reaction has to be characterised.

 

Wir nutzen Cookies auf unserer Website. Einige von ihnen sind technisch notwendig, während andere uns helfen, diese Website zu verbessern oder zusätzliche Funktionalitäten zur Verfügung zu stellen. Weitere Informationen